Which has better earnings and valuation, HQY or ITGR?

HealthEquity has higher earnings, but lower revenue than Integer. HealthEquity is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.36B 5.63 $215.20M $2.77 33.50 Integer $1.85B 2.31 $102.81M $3.66 34.49

Is HQY or ITGR more profitable?

HealthEquity has a net margin of 17.36% compared to Integer's net margin of 6.97%. HealthEquity's return on equity of 15.33% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.36% 15.33% 9.51% Integer 6.97% 12.79% 6.48%

Does the media prefer HQY or ITGR?

In the previous week, HealthEquity had 1 more articles in the media than Integer. MarketBeat recorded 5 mentions for HealthEquity and 4 mentions for Integer. HealthEquity's average media sentiment score of 0.92 beat Integer's score of 0.52 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HQY or MOH?

In the previous week, HealthEquity and HealthEquity both had 5 articles in the media. Molina Healthcare's average media sentiment score of 1.09 beat HealthEquity's score of 0.92 indicating that Molina Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Molina Healthcare 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HQY or OSCR?

In the previous week, Oscar Health had 12 more articles in the media than HealthEquity. MarketBeat recorded 17 mentions for Oscar Health and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.92 beat Oscar Health's score of 0.63 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oscar Health 9 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ALHC or HQY?

In the previous week, Alignment Healthcare had 2 more articles in the media than HealthEquity. MarketBeat recorded 7 mentions for Alignment Healthcare and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.92 beat Alignment Healthcare's score of 0.62 indicating that HealthEquity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alignment Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HQY or CLOV?

In the previous week, HealthEquity had 3 more articles in the media than Clover Health Investments. MarketBeat recorded 5 mentions for HealthEquity and 2 mentions for Clover Health Investments. HealthEquity's average media sentiment score of 0.92 beat Clover Health Investments' score of 0.89 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Clover Health Investments 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

HealthEquity (HQY) Competitors

$92.70 -0.66 (-0.71%)

As of 03:52 PM Eastern

Compare

HQY vs. ITGR, MOH, OSCR, ALHC, and CLOV

Should you buy HealthEquity stock or one of its competitors? HealthEquity's main competitors and comparable companies include Integer (ITGR), Molina Healthcare (MOH), Oscar Health (OSCR), Alignment Healthcare (ALHC), and Clover Health Investments (CLOV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does HealthEquity compare to Integer?

HealthEquity (NASDAQ:HQY) and Integer (NYSE:ITGR) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

HealthEquity has higher earnings, but lower revenue than Integer. HealthEquity is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.36B	5.63	$215.20M	$2.77	33.50
Integer	$1.85B	2.31	$102.81M	$3.66	34.49

HealthEquity has a net margin of 17.36% compared to Integer's net margin of 6.97%. HealthEquity's return on equity of 15.33% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Integer	6.97%	12.79%	6.48%

In the previous week, HealthEquity had 1 more articles in the media than Integer. MarketBeat recorded 5 mentions for HealthEquity and 4 mentions for Integer. HealthEquity's average media sentiment score of 0.92 beat Integer's score of 0.52 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market.

HealthEquity presently has a consensus target price of $111.87, indicating a potential upside of 20.56%. Integer has a consensus target price of $109.86, indicating a potential downside of 12.97%. Given HealthEquity's stronger consensus rating and higher possible upside, equities research analysts clearly believe HealthEquity is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Summary

HealthEquity beats Integer on 13 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Molina Healthcare?

HealthEquity (NASDAQ:HQY) and Molina Healthcare (NYSE:MOH) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Molina Healthcare has higher revenue and earnings than HealthEquity. Molina Healthcare is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.36B	5.63	$215.20M	$2.77	33.50
Molina Healthcare	$44.52B	0.23	$472M	-$0.18	N/A

HealthEquity has a net margin of 17.36% compared to Molina Healthcare's net margin of -0.02%. HealthEquity's return on equity of 15.33% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Molina Healthcare	-0.02%	3.73%	0.97%

In the previous week, HealthEquity and HealthEquity both had 5 articles in the media. Molina Healthcare's average media sentiment score of 1.09 beat HealthEquity's score of 0.92 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Molina Healthcare	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity currently has a consensus target price of $111.87, indicating a potential upside of 20.56%. Molina Healthcare has a consensus target price of $202.44, indicating a potential upside of 4.30%. Given HealthEquity's stronger consensus rating and higher possible upside, equities research analysts clearly believe HealthEquity is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
Molina Healthcare	2 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06

HealthEquity has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.75, indicating that its share price is 25% less volatile than the broader market.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

HealthEquity beats Molina Healthcare on 12 of the 16 factors compared between the two stocks.

How does HealthEquity compare to Oscar Health?

HealthEquity (NASDAQ:HQY) and Oscar Health (NYSE:OSCR) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

HealthEquity has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.37, suggesting that its share price is 137% more volatile than the broader market.

HealthEquity has a net margin of 17.36% compared to Oscar Health's net margin of 3.60%. Oscar Health's return on equity of 38.45% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Oscar Health	3.60%	38.45%	6.76%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 75.7% of Oscar Health shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 22.6% of Oscar Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

HealthEquity has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.36B	5.63	$215.20M	$2.77	33.50
Oscar Health	$15.32B	0.63	-$443.15M	$1.40	22.43

In the previous week, Oscar Health had 12 more articles in the media than HealthEquity. MarketBeat recorded 17 mentions for Oscar Health and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.92 beat Oscar Health's score of 0.63 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Oscar Health	9 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity currently has a consensus price target of $111.87, indicating a potential upside of 20.56%. Oscar Health has a consensus price target of $26.22, indicating a potential downside of 16.49%. Given HealthEquity's stronger consensus rating and higher possible upside, equities research analysts clearly believe HealthEquity is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
Oscar Health	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.42

Summary

HealthEquity beats Oscar Health on 11 of the 16 factors compared between the two stocks.

How does HealthEquity compare to Alignment Healthcare?

Alignment Healthcare (NASDAQ:ALHC) and HealthEquity (NASDAQ:HQY) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

Alignment Healthcare currently has a consensus target price of $23.60, suggesting a potential upside of 82.80%. HealthEquity has a consensus target price of $111.87, suggesting a potential upside of 20.56%. Given Alignment Healthcare's higher possible upside, equities analysts plainly believe Alignment Healthcare is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alignment Healthcare	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85

86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by insiders. Comparatively, 1.6% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Alignment Healthcare had 2 more articles in the media than HealthEquity. MarketBeat recorded 7 mentions for Alignment Healthcare and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.92 beat Alignment Healthcare's score of 0.62 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alignment Healthcare	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a net margin of 17.36% compared to Alignment Healthcare's net margin of 0.89%. Alignment Healthcare's return on equity of 20.02% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alignment Healthcare	0.89%	20.02%	3.46%
HealthEquity	17.36%	15.33%	9.51%

Alignment Healthcare has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

HealthEquity has lower revenue, but higher earnings than Alignment Healthcare. HealthEquity is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alignment Healthcare	$4.58B	0.59	-$720K	$0.19	67.95
HealthEquity	$1.36B	5.63	$215.20M	$2.77	33.50

Summary

HealthEquity beats Alignment Healthcare on 10 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Clover Health Investments?

HealthEquity (NASDAQ:HQY) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

In the previous week, HealthEquity had 3 more articles in the media than Clover Health Investments. MarketBeat recorded 5 mentions for HealthEquity and 2 mentions for Clover Health Investments. HealthEquity's average media sentiment score of 0.92 beat Clover Health Investments' score of 0.89 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Clover Health Investments	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, meaning that its stock price is 147% more volatile than the broader market.

HealthEquity has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.36B	5.63	$215.20M	$2.77	33.50
Clover Health Investments	$2.48B	0.93	-$85.55M	-$0.05	N/A

HealthEquity has a net margin of 17.36% compared to Clover Health Investments' net margin of -0.74%. HealthEquity's return on equity of 15.33% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Clover Health Investments	-0.74%	-4.20%	-2.28%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

HealthEquity currently has a consensus target price of $111.87, indicating a potential upside of 20.56%. Clover Health Investments has a consensus target price of $4.33, indicating a potential upside of 0.19%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

HealthEquity beats Clover Health Investments on 14 of the 17 factors compared between the two stocks.

Get HealthEquity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQY vs. The Competition

Export

Metric	HealthEquity	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$7.69B	$9.91B	$7.15B	$12.79B
Dividend Yield	N/A	2.59%	2.54%	9.15%
P/E Ratio	33.54	34.15	271.90	25.27
Price / Sales	5.63	5.64	697.54	108.08
Price / Cash	18.21	121.42	77.07	52.39
Price / Book	3.86	5.31	10.81	6.34
Net Income	$215.20M	$313.25M	$3.48B	$357.86M
7 Day Performance	-5.84%	-0.08%	-0.91%	-0.06%
1 Month Performance	-11.32%	-0.76%	2.70%	-0.94%
1 Year Performance	-0.22%	15.42%	21.40%	11.89%

HealthEquity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQY HealthEquity	4.5217 of 5 stars	$92.84 -0.6%	$111.87 +20.5%	+0.3%	$7.69B	$1.36B	33.57	2,814
ITGR Integer	2.3194 of 5 stars	$125.32 0.0%	$109.86 -12.3%	+19.2%	$4.26B	$1.85B	34.24	11,000
MOH Molina Healthcare	2.4781 of 5 stars	$198.43 -0.8%	$202.44 +2.0%	+11.8%	$10.44B	$45.43B	N/A	19,000
OSCR Oscar Health	4.1881 of 5 stars	$30.00 -1.5%	$26.22 -12.6%	+62.7%	$9.40B	$11.70B	21.43	2,305	Trending News Insider Trade
ALHC Alignment Healthcare	3.9168 of 5 stars	$13.40 -1.6%	$23.60 +76.1%	-17.0%	$2.83B	$3.95B	70.53	1,849

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HQY) was last updated on 9/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthEquity (HQY) Competitors

HQY vs. ITGR, MOH, OSCR, ALHC, and CLOV

How does HealthEquity compare to Integer?

Summary

How does HealthEquity compare to Molina Healthcare?

Summary

How does HealthEquity compare to Oscar Health?

Summary

How does HealthEquity compare to Alignment Healthcare?

Summary

How does HealthEquity compare to Clover Health Investments?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HealthEquity (HQY) Competitors

HQY vs. ITGR, MOH, OSCR, ALHC, and CLOV

How does HealthEquity compare to Integer?

Which has better earnings and valuation, HQY or ITGR?

Is HQY or ITGR more profitable?

Does the media prefer HQY or ITGR?

Do institutionals and insiders believe in HQY or ITGR?

Which has more volatility and risk, HQY or ITGR?

Do analysts prefer HQY or ITGR?

Summary

How does HealthEquity compare to Molina Healthcare?

Which has higher valuation and earnings, HQY or MOH?

Is HQY or MOH more profitable?

Does the media favor HQY or MOH?

Do analysts prefer HQY or MOH?

Which has more risk & volatility, HQY or MOH?

Do institutionals and insiders believe in HQY or MOH?

Summary

How does HealthEquity compare to Oscar Health?

Which has more risk and volatility, HQY or OSCR?

Is HQY or OSCR more profitable?

Do institutionals & insiders have more ownership in HQY or OSCR?

Which has better valuation and earnings, HQY or OSCR?

Does the media favor HQY or OSCR?

Do analysts prefer HQY or OSCR?

Summary

How does HealthEquity compare to Alignment Healthcare?

Do analysts recommend ALHC or HQY?

Do insiders & institutionals have more ownership in ALHC or HQY?

Does the media refer more to ALHC or HQY?

Is ALHC or HQY more profitable?

Which has more risk & volatility, ALHC or HQY?

Which has better valuation & earnings, ALHC or HQY?

Summary

How does HealthEquity compare to Clover Health Investments?

Does the media favor HQY or CLOV?

Which has more risk and volatility, HQY or CLOV?

Which has stronger earnings and valuation, HQY or CLOV?

Is HQY or CLOV more profitable?

Do institutionals and insiders believe in HQY or CLOV?

Do analysts recommend HQY or CLOV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools